153 related articles for article (PubMed ID: 26670944)
1. IL-6 Antibody and RGD Peptide Conjugated Poly(amidoamine) Dendrimer for Targeted Drug Delivery of HeLa Cells.
Mekuria SL; Debele TA; Chou HY; Tsai HC
J Phys Chem B; 2016 Jan; 120(1):123-30. PubMed ID: 26670944
[TBL] [Abstract][Full Text] [Related]
2. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
3. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
4. Cellular delivery of doxorubicin mediated by disulfide reduction of a peptide-dendrimer bioconjugate.
Burns KE; Delehanty JB
Int J Pharm; 2018 Jul; 545(1-2):64-73. PubMed ID: 29709616
[TBL] [Abstract][Full Text] [Related]
5. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
[TBL] [Abstract][Full Text] [Related]
6. Poly(amidoamine) Dendrimer-Doxorubicin Conjugates: In Vitro Characteristics and Pseudosolution Formulation in Pressurized Metered-Dose Inhalers.
Zhong Q; da Rocha SR
Mol Pharm; 2016 Mar; 13(3):1058-72. PubMed ID: 26832992
[TBL] [Abstract][Full Text] [Related]
7. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
[TBL] [Abstract][Full Text] [Related]
8. Transferrin/α-tocopherol modified poly(amidoamine) dendrimers for improved tumor targeting and anticancer activity of paclitaxel.
Bhatt H; Kiran Rompicharla SV; Ghosh B; Torchilin V; Biswas S
Nanomedicine (Lond); 2019 Dec; 14(24):3159-3176. PubMed ID: 31855118
[No Abstract] [Full Text] [Related]
9. PEGylated Dendrimer-Doxorubicin Cojugates as pH-Sensitive Drug Delivery Systems: Synthesis and In Vitro Characterization.
She W; Pan D; Luo K; He B; Cheng G; Zhang C; Gu Z
J Biomed Nanotechnol; 2015 Jun; 11(6):964-78. PubMed ID: 26353586
[TBL] [Abstract][Full Text] [Related]
10. cRGD mediated redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for efficiently intracellular antitumor drug delivery.
Wang Y; Hu W; Ding B; Chen D; Cheng L
Colloids Surf B Biointerfaces; 2020 Oct; 194():111195. PubMed ID: 32619785
[TBL] [Abstract][Full Text] [Related]
11. Role of generation on folic acid-modified poly(amidoamine) dendrimers for targeted delivery of baicalin to cancer cells.
Lv T; Yu T; Fang Y; Zhang S; Jiang M; Zhang H; Zhang Y; Li Z; Chen H; Gao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():182-190. PubMed ID: 28415453
[TBL] [Abstract][Full Text] [Related]
12. Poly(ethylene glycol) versus dendrimer prodrug conjugates: influence of prodrug architecture in cellular uptake and transferrin mediated targeting.
Aher N; Banerjee S; Bhansali S; Yadav R; Shidore M; Mhaske S; Chaudhari R; Asai S; Jalota-Badhwar A; Khandare J
J Biomed Nanotechnol; 2013 May; 9(5):776-89. PubMed ID: 23802407
[TBL] [Abstract][Full Text] [Related]
13. Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin.
Kono K; Kojima C; Hayashi N; Nishisaka E; Kiura K; Watarai S; Harada A
Biomaterials; 2008 Apr; 29(11):1664-75. PubMed ID: 18194811
[TBL] [Abstract][Full Text] [Related]
14. Polyamidoamine (PAMAM) dendrimers modified with short oligopeptides for early endosomal escape and enhanced gene delivery.
Thuy le T; Mallick S; Choi JS
Int J Pharm; 2015 Aug; 492(1-2):233-43. PubMed ID: 26187169
[TBL] [Abstract][Full Text] [Related]
15. Construction and evaluation of PAMAM-DOX conjugates with superior tumor recognition and intracellular acid-triggered drug release properties.
Cheng L; Hu Q; Cheng L; Hu W; Xu M; Zhu Y; Zhang L; Chen D
Colloids Surf B Biointerfaces; 2015 Dec; 136():37-45. PubMed ID: 26360738
[TBL] [Abstract][Full Text] [Related]
16. RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.
Zhang L; Zhu S; Qian L; Pei Y; Qiu Y; Jiang Y
Eur J Pharm Biopharm; 2011 Oct; 79(2):232-40. PubMed ID: 21496485
[TBL] [Abstract][Full Text] [Related]
17. Octa-arginine modified poly(amidoamine) dendrimers for improved delivery and cytotoxic effect of paclitaxel in cancer.
Rompicharla SVK; Kumari P; Ghosh B; Biswas S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):847-859. PubMed ID: 29790795
[TBL] [Abstract][Full Text] [Related]
18. Preparation of self-assembled core-shell nano structure of conjugated generation 4.5 poly (amidoamine) dendrimer and monoclonal Anti-IL-6 antibody as bioimaging probe.
Mekuria SL; Tsai HC
Colloids Surf B Biointerfaces; 2015 Nov; 135():253-260. PubMed ID: 26263213
[TBL] [Abstract][Full Text] [Related]
19. Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapy.
Khodadust R; Unsoy G; Gunduz U
Biomed Pharmacother; 2014 Oct; 68(8):979-87. PubMed ID: 25458787
[TBL] [Abstract][Full Text] [Related]
20. Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.
Wang K; Zhang X; Zhang L; Qian L; Liu C; Zheng J; Jiang Y
Drug Deliv; 2015 May; 22(3):389-99. PubMed ID: 24670095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
